Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [18F]FDG PET/CT and MRI.
Linz C, Brands RC, Kertels O, Dierks A, Brumberg J, Gerhard-Hartmann E, Hartmann S, Schirbel A, Serfling S, Zhi Y, Buck AK, Kübler A, Hohm J, Lapa C, Kircher M. Linz C, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3951-3960. doi: 10.1007/s00259-021-05422-z. Epub 2021 May 29. Eur J Nucl Med Mol Imaging. 2021. PMID: 34050405 Free PMC article.
Elevated FDG uptake in the lactating human breast.
Dankerl A, Schirrmeister H, Buck A, Reske SN. Dankerl A, et al. Clin Nucl Med. 2001 Jun;26(6):577-8. doi: 10.1097/00003072-200106000-00031. Clin Nucl Med. 2001. PMID: 11353322 No abstract available.
Initial results in the assessment of multiple myeloma using 18F-FDG PET.
Schirrmeister H, Bommer M, Buck AK, Müller S, Messer P, Bunjes D, Döhner H, Bergmann L, Reske SN. Schirrmeister H, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):361-6. doi: 10.1007/s00259-001-0711-3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12002711 Clinical Trial.
Biological characterisation of breast cancer by means of PET.
Buck AK, Schirrmeister H, Mattfeldt T, Reske SN. Buck AK, et al. Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S80-7. doi: 10.1007/s00259-004-1529-6. Epub 2004 May 4. Eur J Nucl Med Mol Imaging. 2004. PMID: 15127240 Review.
Clinical relevance of imaging proliferative activity in lung nodules.
Buck AK, Hetzel M, Schirrmeister H, Halter G, Möller P, Kratochwil C, Wahl A, Glatting G, Mottaghy FM, Mattfeldt T, Neumaier B, Reske SN. Buck AK, et al. Eur J Nucl Med Mol Imaging. 2005 May;32(5):525-33. doi: 10.1007/s00259-004-1706-7. Epub 2004 Dec 14. Eur J Nucl Med Mol Imaging. 2005. PMID: 15599526 Clinical Trial.
Molecular imaging of proliferation in malignant lymphoma.
Buck AK, Bommer M, Stilgenbauer S, Juweid M, Glatting G, Schirrmeister H, Mattfeldt T, Tepsic D, Bunjes D, Mottaghy FM, Krause BJ, Neumaier B, Döhner H, Möller P, Reske SN. Buck AK, et al. Cancer Res. 2006 Nov 15;66(22):11055-61. doi: 10.1158/0008-5472.CAN-06-1955. Cancer Res. 2006. PMID: 17108145
Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Krüger S, Buck AK, Blumstein NM, Pauls S, Schelzig H, Kropf C, Schumann C, Mottaghy FM, Hombach V, Reske SN. Krüger S, et al. Among authors: buck ak. J Intern Med. 2006 Dec;260(6):545-50. doi: 10.1111/j.1365-2796.2006.01729.x. J Intern Med. 2006. PMID: 17116005 Free article.
Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma.
Mottaghy FM, Sunderkötter C, Schubert R, Wohlfart P, Blumstein NM, Neumaier B, Glatting G, Ozdemir C, Buck AK, Scharffetter-Kochanek K, Reske SN. Mottaghy FM, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1355-64. doi: 10.1007/s00259-006-0358-1. Epub 2007 Feb 13. Eur J Nucl Med Mol Imaging. 2007. PMID: 17295038
354 results